AVEO PHARMACEUTICALS INC Contracts & Agreements
141 Contracts & Agreements
- Business Finance (48 contracts)
- Business Operations (11)
- Human Resources (36)
- Intellectual Property (10)
- Mergers & Acquisitions (1)
- Real Estate (11)
- Uncategorized (24)
- Agreement and Plan of Merger, dated October 18, 2022, by and among AVEO Pharmaceuticals, Inc., LG Chem, Ltd. and Acacia Acquisition Sub, Inc (Filed With SEC on October 18, 2022)
- Offer Letter by the Registrant to Michael Ferraresso, dated April 8, 2021 (Filed With SEC on March 14, 2022)
- Severance and Change in Control Agreement, dated March 10, 2021, by and between the Registrant and Michael Ferraresso (Filed With SEC on March 14, 2022)
- Offer Letter by the Registrant to Jebediah Ledell, dated November 12, 2021 (Filed With SEC on March 14, 2022)
- Severance and Change in Control Agreement, dated December 1, 2021, by and between the Registrant and Jebediah Ledell (Filed With SEC on March 14, 2022)
- Executive Severance and Change in Control Plan (Filed With SEC on March 14, 2022)
- Form of Non-Competition and Non-Solicitation Agreement, dated March (Filed With SEC on March 14, 2022)
- Third Amendment to Amended and Restated Loan and Security Agreement, dated March 8, 2022, by and among the Registrant, the several banks and other financial institutions or... (Filed With SEC on March 14, 2022)
- License Agreement, dated December 18, 2015, by and between the Registrant and EUSA Pharma (UK) Limited (Filed With SEC on March 14, 2022)
- First Amendment to Sublease Agreement, dated November 17, 2021, by and between the Registrant and Commonwealth Care Alliance, Inc (Filed With SEC on March 14, 2022)
- Revocable Temporary License Agreement, dated November 17, 2021, by and between the Registrant and Commonwealth Care Alliance, Inc (Filed With SEC on March 14, 2022)
- Amended and Restated License Agreement, dated August 13, 2015, by and between the Registrant and St. Vincents Hospital Sydney Limited (Filed With SEC on November 8, 2021)
- Termination, Separation and Release of Claims Agreement, dated August 27, 2021, by and between AVEO Pharmaceuticals, Inc. and Michael Needle, M.D (Filed With SEC on August 27, 2021)
- Clinical Trial Collaboration and Supply Agreement, dated January 23, 2021, by and between the Registrant and Bristol-Myers Squibb Company (Filed With SEC on May 10, 2021)
- Amendment No. 1 to Clinical Trial Collaboration and Supply Agreement, dated January 26, 2021, by and between the Registrant and Bristol-Myers Squibb Company (Filed With SEC on May 10, 2021)
- Underwriting Agreement, dated March 23, 2021, by and among the Company, SVB Leerink LLC and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on March 24, 2021)
- Option and License Agreement, dated as of March 18, 2009, by and between the Registrant and Biogen Idec International GmbH (Filed With SEC on March 16, 2021)
- Amendment No. 1 to Option and License Agreement, dated as of March 18, 2014 by and between the Registrant and Biogen Idec MA Inc (Filed With SEC on March 16, 2021)
- Second Amendment to Amended and Restated Loan and Security Agreement, dated February 1, 2021, by and among AVEO Pharmaceuticals, Inc., the several banks and other financial... (Filed With SEC on February 2, 2021)
- Separation and Release of Claims Agreement, dated January 25, 2021, by and between AVEO Pharmaceuticals, Inc. and Karuna Rubin (Filed With SEC on January 29, 2021)
- First Amendment to Amended and Restated Loan and Security Agreement, dated as of August 7, 2020, by and among the registrant, Hercules Capital, Inc. and the other lenders named... (Filed With SEC on August 10, 2020)
- Underwriting Agreement, dated June 16, 2020, by and among the Company, SVB Leerink LLC and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on June 17, 2020)
- Sublease, dated March 5, 2020, by and between the Registrant and Commonwealth Care Alliance, Inc (Filed With SEC on April 30, 2020)
- Specimen Stock Certificate evidencing the shares of common stock (Filed With SEC on March 16, 2020)
- Description of Registered Securities (Filed With SEC on March 16, 2020)
- Offer Letter by and between the Registrant and Erick Lucera, dated December 12, 2019 (Filed With SEC on March 16, 2020)
- Severance and Change in Control Agreement, dated January 6, 2020, by and between the Registrant and Erick Lucera (Filed With SEC on March 16, 2020)
- Amendment to License Agreement, dated as of August 1, 2019, by and between AVEO and KKC (Filed With SEC on August 1, 2019)
- Purchase Agreement, dated April 3, 2019, by and between AVEO Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on April 4, 2019)
- Form of Warrant (Filed With SEC on April 4, 2019)
- Offer Letter by and between the Registrant and Karuna Rubin dated June 16, 2015 (Filed With SEC on March 14, 2019)
- Severance and Change in Control Agreement, dated March 13, 2019, by and between the Registrant and Karuna Rubin (Filed With SEC on March 14, 2019)
- Agreement, dated December 18, 2018, by and between the Registrant and Novartis International Pharmaceutical Ltd (Filed With SEC on March 14, 2019)
- Purchase Agreement, dated August 17, 2018, by and between AVEO Pharmaceuticals, Inc. and Piper Jaffray & Co (Filed With SEC on August 17, 2018)
- Warrant Agreement, dated July 16, 2018, by and among AVEO Pharmaceuticals, Inc. and Computershare Inc. and Computershare Trust Company, N.A., acting jointly as Warrant Agent (Filed With SEC on July 16, 2018)
- Stipulation of Settlement, dated January 29, 2018, by and among the Company and the parties named therein (Filed With SEC on May 8, 2018)
- Offer Letter by and between the Registrant and Nikhil Mehta, dated November 10, 2017 (Filed With SEC on March 13, 2018)
- Severance and Change in Control Agreement, dated November 20, 2017, by and between the Registrant and Nikhil Mehta (Filed With SEC on March 13, 2018)
- Sales Agreement, dated February 16, 2018, by and between the Company and Leerink Partners LLC (Filed With SEC on February 16, 2018)
- Amended and Restated Loan and Security Agreement, dated December 28, 2017, by and among the Company and the parties named therein (Filed With SEC on January 2, 2018)
- Memorandum of Understanding, dated December 26, 2017, by and among the Company and the parties named therein (Filed With SEC on December 26, 2017)
- Severance and Change in Control Agreement; dated November 20, 2017, between AVEO Pharmaceuticals, Inc. and Matthew Dallas (Filed With SEC on November 20, 2017)
- TRANSITION, RETIREMENT AND RELEASE OF CLAIMS AGREEMENT (Filed With SEC on August 9, 2017)
- EXHIBIT A INVENTION AND NON-DISCLOSURE AGREEMENT (Filed With SEC on May 17, 2017)
- 30,000,000 Shares AVEOPHARMACEUTICALS, INC. Common Stock PURCHASE AGREEMENT (Filed With SEC on March 29, 2017)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on November 4, 2016)
- AMENDMENT NO. 4 TO LOAN AND SECURITY AGREEMENT (Filed With SEC on August 4, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 13, 2016)
- AVEO PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on May 13, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on May 13, 2016)
- AMENDMENT NO. 4 TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 13, 2016)
- WARRANTAGREEMENT To Purchase Shares of Common Stock of AVEO PHARMACEUTICALS, INC. Datedas of May 13, 2016 (the Effective Date) (Filed With SEC on May 13, 2016)
- Page 1 of 2 (Filed With SEC on March 15, 2016)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions (Filed With SEC on March 15, 2016)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on November 9, 2015)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on May 7, 2015)
- TRANSITION AND SEPARATION AGREEMENT (Filed With SEC on May 7, 2015)
- Page 1 of 2 (Filed With SEC on May 7, 2015)
- Amendment No. 1 to At Market Issuance Sales Agreement (Filed With SEC on May 7, 2015)
- FIRST AMENDMENT TO LEASE (Filed With SEC on March 6, 2015)
- SECOND AMENDMENT TO LEASE (Filed With SEC on March 6, 2015)
- FOURTH AMENDMENT TO LEASE (Filed With SEC on March 6, 2015)
- Confidential Materials omitted and filed separately withthe Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on March 6, 2015)
- AVEO PHARMACEUTICALS, INC. Common Stock (par value $0.001per share) At Market Issuance Sales Agreement (Filed With SEC on February 27, 2015)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. AMENDMENT NO. 3 TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 5, 2014)
- WARRANTAGREEMENT To Purchase Shares of Common Stock of AVEO PHARMACEUTICALS, INC. Datedas of September 24, 2014 (the Effective Date) (Filed With SEC on November 5, 2014)
- THIRD AMENDMENT TO LEASE AND LEASE TERMINATION AGREEMENT (Filed With SEC on November 5, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on May 7, 2014)
- Confidential Materials omitted and filed separately withthe Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on May 7, 2014)
- [AVEO PHARMACEUTICALS LETTERHEAD] (Filed With SEC on May 7, 2014)
- [AVEO PHARMACEUTICALS LETTERHEAD] (Filed With SEC on March 13, 2014)
- [AVEO PHARMACEUTICALS LETTERHEAD] (Filed With SEC on March 13, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on March 13, 2014)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on March 11, 2013)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on March 11, 2013)
- AVEO PHARMACEUTICALS, INC. 6,667,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on January 17, 2013)
- Consulting and Scientific Advisory Board Agreement (Filed With SEC on August 7, 2012)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. OPTION ANDLICENSE AGREEMENT BY AND BETWEEN AVEO... (Filed With SEC on May 9, 2012)
- LEASE by and between BMR-650 E KENDALL B LLC, a Delaware limited liability company and AVEO PHARMACEUTICALS, INC., a Delaware corporation TABLE OF CONTENTS (Filed With SEC on May 9, 2012)
- AMENDMENT NO. 2 TO LOANAND SECURITY AGREEMENT (Filed With SEC on April 4, 2012)
- AVEO Pharmaceuticals, Inc. Restricted Stock Agreement (Filed With SEC on March 30, 2012)
- AMENDMENT NO. 1 TO LOANAND SECURITY AGREEMENT (Filed With SEC on March 30, 2012)
- FIRST AMENDMENT TO CONSENT TO SUBLEASE (Filed With SEC on March 30, 2012)
- Confidential Materials omitted and filed separately with the Securities andExchange Commission. Asterisks denote omissions. RESEARCH AND LICENSE AGREEMENT BY AND BETWEEN AVEO... (Filed With SEC on August 9, 2011)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on August 9, 2011)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 9, 2011)
- AVEO PHARMACEUTICALS, INC. 5,750,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on June 15, 2011)
- CONSULTING AND SCIENTIFIC ADVISORY BOARD AGREEMENT (Filed With SEC on May 12, 2011)
- CONSENT TO SUBLEASE (Filed With SEC on May 12, 2011)
- AVEO Pharmaceuticals, Inc. Restricted Stock Agreement (Filed With SEC on March 11, 2011)
- CONSULTATION AND SCIENTIFIC ADVISORY BOARD AGREEMENT (Filed With SEC on March 11, 2011)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on November 5, 2010)
- CONSULTATION AND SCIENTIFIC ADVISORY BOARD AGREEMENT (Filed With SEC on November 5, 2010)
- Schedule of Investors to Securities Purchase Agreement, by and among AVEO Pharmaceuticals, Inc. and the Investors set forth therein, dated as of October 28, 2010 (Filed With SEC on November 3, 2010)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 3, 2010)
- FIRST AMENDMENT TO THE AMENDED AND RESTATED COLLABORATION LICENSE AGREEMENT BETWEEN OSI PHARMACEUTICALS, INC. AND AVEO PHARMACEUTICALS, INC. (Filed With SEC on August 6, 2010)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 29, 2010)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on June 4, 2010)
- WARRANT AGREEMENT To Purchase Shares of Common Stock of AVEO PHARMACEUTICALS, INC. Dated as of June 2, 2010 (the Effective Date) (Filed With SEC on June 4, 2010)
- WARRANT AGREEMENT To Purchase Shares of Common Stock of AVEO PHARMACEUTICALS, INC. Dated as of June 2, 2010 (the Effective Date) (Filed With SEC on June 4, 2010)
- Signature(s) Guaranteed:Medallion Guarantee Stamp (Filed With SEC on March 9, 2010)
- FIRST AMENDED AND RESTATED LICENSE AND RESEARCHCOLLABORATION AGREEMENT (Filed With SEC on March 9, 2010)
- Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Asterisks denote omissions. (Filed With SEC on March 9, 2010)
- AVEO PHARMACEUTICALS, INC. [ ] Sharesof Common stock Underwriting Agreement (Filed With SEC on February 23, 2010)
- GenPath Pharmaceuticals, Inc. 2002 STOCK INCENTIVE PLAN (Filed With SEC on February 23, 2010)
- AVEO PHARMACEUTICALS, INC. 2010 STOCK INCENTIVE PLAN (Filed With SEC on February 23, 2010)
- AVEO PHARMACEUTICALS, INC. 2010 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on February 23, 2010)
- GenPath Pharmaceuticals, Inc. 2002 STOCK INCENTIVE PLAN (Filed With SEC on February 8, 2010)
- AVEO PHARMACEUTICALS, INC. 2010 STOCK INCENTIVE PLAN (Filed With SEC on February 8, 2010)
- AVEO PHARMACEUTICALS, INC. Incentive Stock Option Agreement Granted Under 2010 Stock Incentive Plan (Filed With SEC on February 8, 2010)
- AVEO PHARMACEUTICALS, INC. Nonqualified Stock OptionAgreement Granted Under 2010 Stock Incentive Plan (Filed With SEC on February 8, 2010)
- AVEO PHARMACEUTICALS, INC. 2010 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on February 8, 2010)
- GenPath Pharmaceuticals, Inc. 2002 STOCK INCENTIVE PLAN (Filed With SEC on December 16, 2009)
- AVEO Pharmaceuticals, Inc. Incentive Stock Option Agreement Granted Under 2002 Stock Incentive Plan (Filed With SEC on December 16, 2009)
- AVEO Pharmaceuticals, Inc. Nonstatutory Stock OptionAgreement Granted Under 2002 Stock Incentive Plan (Filed With SEC on December 16, 2009)
- AVEO Pharmaceuticals, Inc. Restricted Stock Agreement Granted Under 2002 Stock Incentive Plan (Filed With SEC on December 16, 2009)
- AVEO PHARMACEUTICALS, INC. KEY EMPLOYEE CHANGE INCONTROL SEVERANCE BENEFITS PLAN (Filed With SEC on December 16, 2009)
- Amended and Restated EMPLOYMENT AGREEMENT (Filed With SEC on December 16, 2009)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on December 16, 2009)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on December 16, 2009)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on December 16, 2009)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on December 16, 2009)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on December 16, 2009)
- CONSULTATION AND SCIENTIFIC ADVISORY BOARD AGREEMENT (Filed With SEC on December 16, 2009)
- AMENDED AND RESTATED CONSULTING AND SCIENTIFICADVISORY BOARD AGREEMENT (Filed With SEC on December 16, 2009)
- MASTER SECURITY AGREEMENT (Filed With SEC on December 16, 2009)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on December 16, 2009)
- SUBLEASE (Filed With SEC on December 16, 2009)
- SUBLEASE AGREEMENT (Filed With SEC on December 16, 2009)
- Confidential Materials omitted and filed separately with the Securities andExchange Commission. Asterisks denote omissions. EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on December 16, 2009)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. (Filed With SEC on December 16, 2009)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. FIRST AMENDED AND RESTATED LICENSE AND (Filed With SEC on December 16, 2009)
- Confidential Materials omitted and filed separately with the Securities andExchange Commission. Asterisks denote omissions. LICENSE AND RESEARCH COLLABORATION (Filed With SEC on December 16, 2009)
- Confidential Materials omitted and filed separately withthe Securities and Exchange Commission. Asterisks denote omissions. RESEARCH, DEVELOPMENT AND LICENSE AGREEMENT By... (Filed With SEC on December 16, 2009)
- Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Asterisks denote omissions. (Filed With SEC on December 16, 2009)
- Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Asterisks denote omissions. (Filed With SEC on December 16, 2009)
- AVEO PHARMACEUTICALS, INC. FOURTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on December 16, 2009)
- WARRANT TO PURCHASE STOCK (Filed With SEC on December 16, 2009)
- To Purchase Shares of the Preferred Stock of AVEO PHARMACEUTICALS, INC. (Filed With SEC on December 16, 2009)
- To Purchase Shares of Stock of AVEO PHARMACEUTICALS, INC. Dated as of May 15, 2008 (the Effective Date) (Filed With SEC on December 16, 2009)
- To Purchase Shares of Stock of AVEO PHARMACEUTICALS, INC. Dated as of May 15, 2008 (the Effective Date) (Filed With SEC on December 16, 2009)